2 vials Save $52.50

Retatrutide 10mg

Lyophilized research peptide

$137.49

Wolverine 10mg

2-component research blend

$124.99

Research bundle · 2 vials

Retatrutide 10mg + Wolverine 10mg Research Bundle

USA Made, ≥99% Purity Per Compound

Separate retail vials: Retatrutide 10mg; Wolverine 10mg (BPC-157 5mg + TB-500 5mg)
USA manufactured in a Certified GMP California and Arizona laboratory.
≥99% purity target per compound with third-party HPLC, mass spectrometry, and batch-specific COAs

Combined retail value$262.48

Bundle saving−$52.50

$209.98 $262.48 Save $52.50

Each vial ships in its original retail format with its own batch COA

Dispatched from a US warehouse within 48 hours, tracked

Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Per-compound specifications

2 vials

Nothing in this bundle is co-formulated. Each vial keeps its own identity, purity target, and certificate, and is specified separately below.

Vial 01

Retatrutide 10mg

Sequence

Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-Lys(AEEA-γGlu-C20 diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

CAS: 2381089-83-2
Molecular mass: 4,731.33 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Vial 02

Wolverine 10mg

Sequences

BPC-157: GEPPPGKPADDAGLV; TB-500: Ac-LKKTETQ

CAS: BPC-157: 137525-51-0; TB-500: 885340-08-9
Molecular mass: BPC-157: 1,419.5 g/mol; TB-500: 889.01 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Form: 2 Separate Lyophilized Powders
Purity target: ≥99% per compound (3rd-Party HPLC Tested)
Origin: All Included Products: Synthesized, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is the Retatrutide and Wolverine Research Bundle?

This research bundle pairs Retatrutide 10mg with the 10mg Wolverine blend. Retatrutide is an investigational 39-amino-acid triple-receptor agonist, while Wolverine contains BPC-157 5mg plus TB-500 5mg in one formulated vial.

The two retail products remain separate, giving researchers a clear way to examine nutrient- and energy-signaling pathways alongside vascular, cell-migration, and actin-related models. The bundle format does not establish or promise a combined effect.

How It Works

Retatrutide engages three receptor pathways: GIPR, GLP-1R, and GCGR provide a triple-signaling profile for controlled study.

Wolverine brings two defined peptide signals: BPC-157 is studied in VEGFR2/Akt/eNOS and migration models, while TB-500 represents an actin-binding motif.

Separate retail vials maintain clarity: Retatrutide remains independent from the internally blended Wolverine formulation throughout storage and research design.

Analytical data

One certificate per vial

Independent third-party HPLC assesses each compound against its ≥99% purity target, while mass spectrometry confirms identity. For each vial, the results are documented in one combined, batch-specific COA report.

Lot: RE-43145
Reported: 2026-04-23
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.46%
Net content: 10.02 mg
Appearance: White lyophilized powder

Download COA

Why Source from 321 Peptides?

Domestic accountability.

All included compounds are synthesized, manufactured, and finished in Certified GMP California and Arizona laboratory facilities—never sourced from overseas or Mexico. That means direct domestic supply-chain accountability from production through fulfillment.

Verification you can inspect.

Protected in transit.

Every included product is freeze-dried to help preserve stability during storage and shipping. Rapid domestic fulfillment reduces unnecessary time and handling.

Lot history 7 released lots

Every batch released under each vial in this bundle, with the figure reported for each. Vials are shipped from current stock.

Compound	Lot	Reported	Purity	Net content	COA
Retatrutide 10mg	R1399	2026-06-01	99.79%	11.74 mg	PDF
	RE-43145	2026-04-23	99.46%	10.02 mg	Pending
	RE-44299	2026-04-08	99.83%	10.04 mg	Pending
	RE-43722	2026-03-19	99.58%	10.03 mg	Pending
Wolverine 10mg	WO-55604	2026-05-12	99.52%	10.08 mg	Pending
	WO-54450	2026-05-06	99.88%	10.06 mg	Pending
	WO-55027	2026-05-02	99.71%	10.07 mg	Pending

Frequently Asked Questions

What comes in the Retatrutide and Wolverine bundle?

The bundle includes Retatrutide 10mg; Wolverine 10mg (BPC-157 5mg + TB-500 5mg). Each retail product arrives in its original lyophilized vial with batch-specific COA documentation.

What is the difference between Retatrutide and Wolverine?

Retatrutide is a single investigational peptide designed for triple-receptor activity. Wolverine is a two-peptide blend containing BPC-157 5mg and TB-500 5mg for cellular-signaling research.